Cln1p and Cln2p are considered as equivalent cyclins on the basis of sequence homology, regulation, and functional studies. Here we describe a functional distinction between the Cln1p and Cln2p cyclins in the control of the G1/S transition. Inactivation of CLN2, but not of CLN1, leads to a larger-thannormal cell size, whereas overexpression of CLN2, but not of CLN1, results in smaller-than-normal cells. Furthermore, mild ectopic expression of CLN2, but not of CLN1, suppresses the lethality of swi4swi6 and cdc28 mutant strains. In the absence of Cln1p, the kinetics of budding, initiation of DNA replication, and activation of the Start-transcription program are not affected; by contrast, loss of Cln2p causes a delay in bud emergence. A primary role for Cln2p but not for Cln1p in budding is reinforced by the observation that only the cln2 mutation is synthetic lethal with a cdc42 mutation, and only the cln2 mutant strain is hypersensitive to latrunculin B. In addition, we found that Cln1p showed a more prominent nuclear staining than Cln2p. Finally, chimeric proteins composed of Cln1p and Cln2p revealed that Cln2p integrity is required for its functional specificity.
F UNCTIONAL redundancy is a recurrent strategy family: only one of the CLN genes is necessary to pass through Start since loss of any two CLNs is tolerated by in cell cycle progression. Over the last few years, the characterization of the molecular mechanism of many the cell (Richardson et al. 1989; Cross 1990 ). However, this genetic redundancy must not be interpreted as funccell cycle processes has often revealed the existence of related proteins involved in the same molecular functional redundancy in vivo, since Cln3p is clearly functionally distinct from the other two G1 cyclins (Tyers tion. This is clearly manifested in the case of the primary regulators of the cell cycle: the cyclins and the cyclinet al. 1993) . It shares a low sequence similarity with Cln1p and Cln2p and unlike the CLN1 and CLN2 genes, dependent kinases (CDK). Progression through the cell which are periodically transcribed at the G1/S transition cycle is governed by the sequential activation of the (Wittenberg et al. 1990) , the expression of CLN3 inCDKs, which depends on their physical association with creases only slightly at the G1/M border (McInerny et a cyclin regulatory subunit. Eukaryotic cells contain mulal. 1997) . Furthermore, Cln3p is a very-low-abundance tiple cyclin-CDK complexes (Morgan 1997; Roberts protein with a much weaker associated kinase activity 1999). In the case of the yeast Saccharomyces cerevisiae, relative to Cln1p and Cln2p, and both its protein and nine different cyclins (Cln1p-3p and Clb1p-6p) activate kinase activity levels are roughly constant throughout the Cdc28p protein, the only yeast CDK with an essential the cell cycle, as opposed to the sharp periodic accumufunction in cell cycle progression (reviewed in Nasmyth lation of both Cln1p and Cln2p at the G1/S transition 1996; Andrews and Measday 1998; Mendenhall and (Tyers et al. 1993) . The characterization of the molecuHodge 1998; Miller and Cross 2001a) . Although diflar mechanism constituting Start revealed that the funcferent complexes are required for distinct cell cycle tion of Cln3p is to activate a transcription program events, an extensive overlap between the functions of mediated by the transcriptional factors SBF and MBF diverse cyclin-CDK kinase activities has often been de- (Dirick et al. 1995; Stuart and Wittenberg 1995) . In scribed. A good example of this is the case of the S.
contrast, Cln1p and Cln2p, which are synthesized as cerevisiae G1 cyclins in the control of the initiation of a consequence of this transcriptional activation wave, the cell cycle (Start) at the G1/S transition (Cross control the trigger of post-Start processes such as bud-1995). There are three G1 cyclins in S. cerevisiae: Cln1p, ding, spindle pole body duplication, and the initiation Cln2p, and Cln3p (Cross 1988; Nash et al. 1988 ; Hadof DNA replication. More recently, intrinsic differences wiger et al. 1989) . They constitute an essential gene in the specificity of action and subcellular localization between Cln3p-Cdc28p and Cln1,2p-Cdc28p have been reported (Levine et al. 1996; 1 Schwob et al. 1994; Schneider et al. 1996;  were achieved by using a DNA fragment amplified from plas- et al. 1997) ; turn off the degradation of the mid pFA6a-kanMX6 (a gift from J. R. Pringle). The JCY357
Henchoz
Clb cyclins by inactivating the anaphase-promoting comand JCY404 were derived from W3031-A and JCY220, respectively, by substituting the SWI4 promoter by a DNA fragment plex (APC) Cdh1 ubiquitin ligase (Amon et al. 1994;  amplified from plasmid pFA6a-kanMX6-GAL-HA (gift from was first cloned into EcoRI-XbaI-cleaved YCplac33; this plasmid cesses. Surprisingly, however, the loss of CLN1 had no was then digested with XbaI-SphI and a XbaI-SphI fragment detectable effect on the cell size. This was an unexpected containing a region from ϩ601 to ϩ1638 of the CLN2 gene result, since a previous study reported that cln1 mutant fused to a sequence coding for three copies of the HA epitope cells were larger than wild type but smaller than cln2 was subsequently cloned. Note that an insertion of two amino acids occurs at the join point as a consequence of the introducmutant cells (Tyers et al. 1993 Figure 1D ), were introduced in the wild-type immunoprecipitated fraction by Western analysis using 12C5A (Roche) and anti-Cdc28p (gift from M. Aldea) antibodies.
strain and the effect of the overexpression of CLN1 and
The other half was used in the kinase activity assay. For this assay, CLN2 on the cell size was investigated. It was known 
Cln1p, is primarily involved in the proper execution of
Cell size analysis: Cell size was analyzed in exponentially growing cells after brief sonication in a particle count and the G1/S transition, whereas Cln1p is required only size Analyzer Z2 (Coulter, Hialeah, FL). Graphs are the mobile whenever Cln2p is absent.
average of histograms derived from values from at least six
The experiments described so far were carried out independent cultures. with yeast strains derived from W303-1a. To ask if the Miscellaneous: Western blot analysis, Northern analysis, different cell size phenotypes that we observed for the fluorescence-activated cell sorter (FACS) analysis, and indirect immunofluorescence were carried out as described previously cln1 and cln2 mutants were specific to the strain back- (Queralt and Igual 2003) . An estimation of the intensity of ground, we deleted or overexpressed CLN1 or CLN2 in the cytosolic and nuclear signal in the immunofluorescence another unrelated wild-type background (CG379). As assays was achieved by determining the ratio between the for the W303 background, loss or overexpression of average pixel intensity in the cytosolic and that in the nuclear CLN1 did not affect the cell-size distribution in an exporegion of the cell (as deduced from DAPI signal); Ͼ100 cells from at least three independent assays were analyzed for each nentially growing population. By contrast, the loss of strain.
CLN2 caused a dramatic increase in cell size, whereas the overexpression of CLN2 caused a reduction in cell size, a result very similar to that observed in the W303-RESULTS 1A background (data not shown). This suggests that the different effect on the cell size of the closely related The deletion of CLN2, but not CLN1, causes an increase in cell size: It is well established that the inactivaCln1p and Cln2p proteins, which must reflect a differential requirement for these two cyclins in the G1/S transition or overexpression of regulators of Start produces an altered cell size (Cross 1988; Nash et al. 1988 Nash et al. , 2001  tion, is a general property of S. cerevisiae. The observed phenotypic differences could reflect Hadwiger et al. 1989; Wijnen et al. 2002; Queralt and Igual 2003) . We examined the size of the cln1 and cln2 intrinsic functional differences between Cln2p and Cln1p or differences in the levels of the proteins and/ cells in exponentially growing cultures using a Coulter chanellizer. As shown in Figure 1A , deletion of CLN2 or their associated kinase activities. Both Cln1p and Cln2p are unstable proteins, with half-lives in the range caused a dramatic increase in cell size, consistent with previous reports (Tyers et al. 1993) . The increase in of 5-10 min (Wittenberg et al. 1990; Salama et al. 1994; Barral et al. 1995; Lanker et al. 1996 ; Willems cell size is similar to that observed in a mutant defective in CLN3. This result was expected considering Schneider et al. 1998) , and the specific activity of their associated kinase activity is indeed very Cln2p is a positive regulator of Start downstream pro- 
, and cln2cln3 ( JCY317) was determined in a Coulter cell counter. (B) Wild type (W303-1A) transformed with a control vector (YCp50), or plasmids overexpressing either the CLN1 (ptetO:CLN1) or the CLN2 (ptetO:CLN2) genes under the control of the doxycycline-regulated tetO 2 promoter, were grown on synthetic medium, and cell sizes were determined. (C) Size of cln1cln2 cells ( JCY306) transformed with the control vector (YCp50), the ptetO:CLN1, or the ptetO:CLN2 plasmid, in exponentially growing cultures in the presence of 0.05 g/ml doxycycline. (D) Western analysis of Cln1p and Cln2p protein levels in extracts from the cln1cln2 strain ( JCY306) bearing a centromeric plasmid containing a HA-tagged version of the CLN1 or CLN2 genes or the ptetO:CLN1 or ptetO:CLN2 centromeric plasmid, which expresses the HA-tagged version of CLN1 or CLN2 under the control of the tetO 2 promoter. The cells transformed with either the ptetO:CLN1 or the ptetOCLN2 plasmid were grown in the absence or in the presence of 0.05 g/ml doxycycline, as indicated. Control extract from cells transformed with an empty vector was included (lane no tag). A nonspecific band that cross-reacts with the 12CA5 antibody is shown as the loading control. (E) Specific kinase activity in HA-immunoprecipitates from extracts of the cln1cln2 strain ( JCY306) containing either the ptetO:CLN1 or the ptetO:CLN2 plasmid and grown in the presence of 0.05 g/ml doxycycline. similar (Tyers et al. 1993) . Therefore it is expected that the expression of both cyclins under the control of the same promoter would provide the cells with a similar amount of protein and associated kinase activity for each cyclin. The different effects of the tetO 2 :CLN2 and tetO 2 :CLN1 genes on the cell size described above point in fact to the existence of intrinsic differences between the two cyclins, although the experiment relies on nonnatural dosage conditions, and the genomic CLN1 and CLN2 genes are also present. To obtain a more definitive proof, the plasmids containing the tetO 2 :CLN2 or tetO 2 :CLN1 genes were introduced in a cln1cln2 mutant strain, and the doxycycline concentration was adjusted to 0.05 g/ml. Under this condition, cells contain either CLN2, manifested a larger-than-normal cell size ( Figure  1C ). This result strongly suggests that the observed differences in cell size phenotypes reflect intrinsic funcable to allow growth at the restrictive temperature (Figtional differences between the Cln1p and Cln2p cyclins ure 2B). These results indicate that moderate levels of and are not due to differences in the protein or kinase Cln2p, but not of Cln1p, can compensate for a defect in activity levels present in the cell.
the execution of Start, and they reinforce the conclusion The mild ectopic expression of CLN2, but not CLN1, that Cln2p, rather than Cln1p, is the primary regulator efficiently suppresses the lethality of Start-mutant of the G1/S transition. strains: To further explore the functional distinction Bud emergence is primarily controlled by Cln2p, but between Cln1p and Cln2p, we next analyzed suppresnot by Cln1p: At Start, different processes are switched sion of the Start-defective phenotype of a swi4swi6 douon depending on the CLN function. To test whether ble-mutant strain by ectopic expression of CLN1 or the different requirements for Cln1p and Cln2p affect CLN2. A strain lacking both SWI4 and SWI6 is unable all Start events or simply one specific process, wild type, to activate the G1-S-phase transcriptional program; the cln2, and cln1 cells were arrested with ␣-factor, and the essential function of these transcription factors is to turn timing of budding, initiation of DNA replication, and on G1 cyclin gene expression since ectopic expression of activation of the Start transcription program was ana-CLN2 from the Schizosaccharomyces pombe adh1 promoter lyzed after the release from the arrest. As shown in restores growth of the double-mutant strain (Nasmyth Figure 3 , cln1 mutant cells activate all three processes and Dirick 1991). Consistent with this result, we found with similar kinetics as the wild-type strain, confirming that mild ectopic expression of CLN2 from the tetO 2 that Cln1p plays a secondary role in Start control. With promoter in the presence of 0.5 g/ml doxycycline also regard to the cln2 mutant cells, no significant differsuppresses the growth defect of a swi4swi6 mutant strain ences in the kinetics of the activation of transcription (Figure 2A ). By contrast, the mild overexpression of or the initiation of DNA replication were detected when CLN1 is unable to efficiently rescue the lethality of the compared to wild-type and cln1 cells, yet, remarkably, swi4swi6 mutant strain. This result is consistent with budding was delayed by ‫01ف‬ min. This is an interesting previous observations pointing to a better suppression result, which indicates that Cln2p is the rate-limiting of the swi4mbp1 and swi4swi6ssd1-d mutant strains by factor for the proper execution of bud emergence, but CLN2 than by CLN1 (see Wijnen and Futcher 1999, not for the other Start events. The delay in budding Table 3 ). Only under conditions of overexpression (i.e., could certainly account for the increased cell size obcells grown in the absence of doxycycline) was CLN1 served in the cln2 mutant strains. able to suppress the growth defect of the swi4swi6 strain Bud emergence requires polarization of actin cy-(data not shown). The same result was obtained with toskeleton to a particular site in the cell surface. To get another strain defective in Start, the cdc28-13 mutant strain: only the mild ectopic expression of CLN2 was a more definitive proof of the functional distinction between Cln2p and Cln1p in the control of bud emerperatures of the cln1cdc42 and the parental cdc42 strain revealed that the loss of CLN1 had no effect at all on gence, we investigated the requirement of each cyclin for viability in cells that are defective in polarization growth ( Figure 4A ). In the case of CLN2, however, a direct disruption of the gene in the cdc42 strain could and budding because of a mutation in the CDC42 gene (Adams et al. 1990 ) or in cells whose actin cytoskeleton not be obtained after several attempts, which suggested that the inactivation of cln2 could be deleterious in the is perturbed by the addition of the actin-polymerizing inhibitor latrunculin B to the medium. First, we attempted cdc42 strain. To obtain a cln2cdc42 double mutant, we disrupted the CLN2 gene in a cdc42 strain carrying a to delete CLN1 or CLN2 in a strain carrying a thermosensitive allele of CDC42. We readily obtained a CLN1 displasmid expressing the wild-type CLN2 gene from the tetO 2 promoter. In this strain, the viability of the cln2cdc42 ruption strain, and the growth analysis at different tem-between Cln1p and Cln2p was due to differences in their localization. It has been previously reported that both cyclins are located in the cytoplasm and in the nucleus (Blondel et al. 2000; Cross 2000, 2001b; Edgington and Futcher 2001) and, in the case of Cln2p, that the nuclear and the cytosolic protein pools have specific functions. However, it is difficult from these studies to rule out the existence of subtle differences in the localization of Cln1p and Cln2p, and, moreover, Cln1p localization was assayed only in cells overexpressing the cyclin. To address this point, we analyzed the subcellular distribution of both cyclins in parallel indirect immunofluorescence assays ( Figure 5 ). When Cln2p subcellular localization was analyzed, the signal was detected through the whole cell, with a punctuate pattern in the cytoplasm, in concordance with published results. Cln1p staining was also observed throughout whole cells, but significant differences were detected when compared to the Cln2p localization: the cytosolic punctuate pattern characteristic of Cln2p was barely detected for Cln1p, and the intensity of nuclear spots was notably higher in the case of Cln1p. In fact, function: In a first attempt to characterize the determinants of the Cln2p-specific functionality, a swapping experiment was carried out by interchanging the C-terminal double mutant can be assessed by assaying growth in the presence of doxycycline, which repressed the tetO 2 :CLN2 two-thirds of the CLN1 and CLN2 genes. Thus, two chimeric cyclins were constructed composed of amino expression. As observed in Figure 4B . Expression of the chimeric cyclins was confirmed by Western analysis, which but not Cln1p, becomes essential.
Next, the growth of the cln2 and cln1 mutant strains also revealed that both chimeric cyclins are present at similar protein levels (data not shown). The chimeric in the presence of different concentrations of the actindepolymerizing drug latrunculin B was investigated.
cyclins were then introduced into the cln2 and cln1cln2 mutant strains, and their ability to behave like Cln1p The loss of CLN2 caused cells to be hypersensitive to the drug: cln2 cells failed to grow in the medium suppleor Cln2p was investigated by cell-size determination assays. As is shown in Figure 6 , A and B, whereas the mented with 50 m of latrunculin B, a concentration at which cln1 and wild-type cells grow properly (Figure presence of a plasmid containing the CLN2 gene restores a wild-type cell size in both strains, the two chime-4C). This result indicates that when the actin cytoskeleton is perturbed, Cln2p, but not Cln1p, becomes essenric cyclins failed to suppress the cell-size defect caused by the cln2 mutation. In fact, the effect of both chimeras tial, and it reinforces the conclusion that Cln2p is playing a crucial morphogenetic function for a proper G1/S on cell size was very similar to that observed with a plasmid containing the CLN1 gene. Next, the ability of transition and that this function is specific to Cln2p and not shared with Cln1p.
the chimeric cyclins to suppress the hypersensitivity of the cln2 mutant strain to latrunculin B was investigated. Difference in the subcelluar localization of Cln1p and Cln2p: It is possible that the functional difference
As can be seen in Figure 6C , whereas a plasmid con- taining the CLN2 gene restored growth of the cln2 murectly, the initiation of DNA replication. To date both cyclins are considered highly related on the basis of tant strain in the presence of latrunculin B, plasmids expressing any of the two chimeric cyclin genes or an their regulation and function. Both Cln1p and Cln2p extra copy of the CLN1 gene failed to support growth. protein levels are controlled by the same transcriptional All these results indicated that both chimeric cyclins (Nasmyth and Dirick 1991; Ogas et al. 1991 ) and behave like a genuine Cln1p and none of them is able posttranscriptional mechanisms (Barral et al. 1995 ; to carry out the specific function of Cln2p, suggesting Willems et al. 1996; Skowyra et al. 1997) and both that regions located along the whole protein are imporcyclins take part in many common functions, such as tant to confer functional specificity to Cln2p in relation induction of growth polarization and budding (Benton to Cln1p. In other words, the fact that the substitution Schwob et al. 1994; Schneider et al. 1996 ; functional distinction between Cln1p and Cln2p in the Henchoz et al. 1997) , inactivation of the APC complex control of the mitotic cycle. (Amon et al. 1994; Huang et al. 2001) , repression of Finally, the subcellular localization of the chimeric pheromone-induced transcription (Oehlen and Cross cyclins was analyzed. Both proteins are distributed in 1998; Wu et al. 1998), or stimulation of pseudohyphal the cytoplasm and in the nucleus. However, the Cln1p N -growth (Ahn et al. 2001) . Thus, the extensive work carCln2p C cyclin is relatively more abundant in the nucleus ried out on these two cyclins has revealed an extraordithan the Cln2p N -Cln1p C cyclin ( Figure 6D ). This result nary similarity between them. However, in this work, we is similar to that observed for Cln1p and suggests that show an important difference in the cellular requiresequences in the N-terminal half of the cyclins are rement for Cln1p and Cln2p in executing the G1/S transisponsible for the more efficient accumulation inside tion. We find that (1) inactivation of CLN2, but not of the nucleus of Cln1p in comparison to Cln2p.
CLN1, led to an increase in cell size, and reciprocally, overexpression of CLN2, but not of CLN1, caused a reduction in cell size; (2) mild ectopic expression of DISCUSSION CLN2, but not of CLN1, suppresses the cdc28 and swi4swi6 Start-defective mutants; (3) the cln2 mutation, The main function of the closely related Cln1p and but not the cln1 mutation, originates a delay in the Cln2p cyclins is to switch on the events of bud emergence, spindle pole body (SPB) duplication, and, inditiming of bud emergence; and (4) the cln2 mutation, but not the cln1 mutation, is synthetically lethal with a G1/S transition during the mitotic cycle, with the Cln1p protein playing a very minor role. cdc42 mutation and causes hypersensitivity to perturbations in the actin cytoskeleton. On the basis of genetic In addition to the numerous reports outlining the similarity between Cln1p and Cln2p, some differences interactions (Benton et al. 1993; Cvrckova and Nasmyth 1993) and the kinetics of budding (Dirick et have been previously described. The transient delay in cell cycle progression and the concomitant increase in al. 1995) in a cln1cln2 mutant strain, it was previously suggested that Cln1p and Cln2p are involved in bud cell size observed when cells grown on nonfermentable carbon sources are shifted to glucose-containing meemergence. Our results, however, enable us to conclude that Cln2p is the primary regulator of budding at the dium are dependent upon Cln1p, but not on Cln2p (Tokiwa et al. 1994; Flick et al. 1998) . However, this expression of the particular cyclin. However, other experimental data support the opposite viewpoint, in difference is due to the specific repression of CLN1 gene transcription after the addition of glucose and does not which the cyclin identity might be essential for the specialization of the different cyclin-CDK complexes by mereflect intrinsic functional differences between Cln1p and Cln2p. In fact, Flick et al. found that Cln2p, when diating interactions with specific substrates or regulators and/or localizing the kinases in different subcellular it is expressed under the control of the CLN1 promoter, is as efficient as Cln1p in adapting cell size to a new compartments. It is most likely that a combination of these mechanisms, and/or additional factors not yet carbon source, so the mechanism relies on a reduction in CLN expression independently of the nature of the characterized, contributes to cyclin-CDK specificity. Which mechanisms account for the functional distinccyclin. In other words, the fact that adaptation of cell size to new conditions is accomplished by a reduction tion between Cln1p-Cdc28p and Cln2p-Cdc28p that we have characterized? First, Cln1p/Cln2p functional specin CLN1 expression suggests that Cln1p could be playing a more prominent role in slowly growing cells on poor ificity may reflect differences in the period of the cycle in which the cyclin is expressed or in their protein levels. carbon sources than in rapidly growing cells on glucose. On the other hand, it has also been reported that Cln1p
However, this explanation can probably be ruled out because Cln1p and Cln2p are both present in the cell is required for pseudohyphal development, whereas Cln2p is dispensable for this process (Loeb et al. 1999;  during the same period of the cycle, and the difference between both cyclins is still observed when they are ectopiMadhani et al. 1999). However, as discussed in Loeb et al., CLN transcripts are not sufficiently abundant for an cally expressed under the control of the same promoter. Moreover, the Cln2p N -Cln1p C chimeric cyclin, which is accurate detection under the experimental conditions used, so it is possible that this difference between Cln1p expressed from the CLN2 promoter, has lost the specific functionality of Cln2p. Second, Cln1p and Cln2p may and Cln2p could also reflect variations in gene expression rather than intrinsic functional differences behave differences in their association with or the activation of the Cdc28p kinase. However, published results tween the cyclins. In fact, Madhani et al. report that the induction of pseudohyphal development (at least under (Tyers et al. 1993) , as well as our work, do not support this model because the specific activities of the Cln1p-some conditions) is associated with an increase in CLN1 gene expression (CLN2 gene expression was not anaCdc28p and Cln2p-Cdc28p kinases in the cell are very similar. A third possibility that could explain the funclyzed in this study). Finally, a cln2 mutant strain initiates meiosis more rapidly than the wild type, in contrast to tional specificity of Clnp-Cdc28p complexes is the control of the subcellular localization of the complex by the much more modest effect observed in the cln1 mutant strain (Purnapatre et al. 2002) . This has led to the cyclin partner. Strong evidence for this mechanism comes from studies on the specific functions of Cln2p-the conclusion that CLN2 is more active than CLN1 in repressing the transition from cell division to meiotic and Cln3p-associated kinases (Edgington and Futcher 2001; Cross 2000, 2001b) . In the differentiation. Cells must reach a critical size before they can initiate meiosis and it has been proposed that case of Cln1p and Cln2p, both cyclins are distributed in the nucleus and in the cytoplasm, but there are sigthe effect of CLN in the initiation of meiosis could result from its effect on cell size (Calvert and Dawes 1984;  nificant differences since Cln1p shows a higher proportion of nuclear accumulation than Cln2p does. Budding Purnapatre et al. 2002) . Thus, cln3 or cln1cln2 mutants are larger than normal and accelerate entry into meiosis, is a process that involves reorganization of the cytoskeleton and the cell surface, so the relative higher abunwhereas cells overexpressing CLN3 are smaller than normal and delay meiosis initiation. In this context, the dance of Cln2p in the cytosol could help to explain the specific role that Cln2p plays in this process. Finally, different roles of CLN1 and CLN2 in the control of cell size that we have described here could explain the an additional mechanism that could contribute to the functional distinction between cyclin-CDK complexes is differences observed in the timing of meiosis initiation between the cln1 and cln2 mutant strains: cln2 mutation, the ability of cyclins to mediate critical protein interactions, which target the kinases to specific substrates. It but not cln1 mutation, will produce larger cells and, consequently, an accelerated entry in meiosis.
is interesting to note that the N-terminal regions of Cln1p and Cln2p, which contain the cyclin box, are In S. cerevisiae, a single CDK, Cdc28p, associates with nine different cyclins to govern progression through the highly similar (74% identity). However, conservation is relaxed in their C-terminal regions (45% identity). This cell cycle. The mechanism by which the cyclin partner confers functional specificity on the different cyclinwould suggest that the elements responsible for the distinction between both cyclins (for instance, specific Cdc28p kinases is still a matter of some controversy (reviewed in Roberts 1999; Miller and Cross 2001a) .
protein-interacting domains) could be located in the C-terminal portions of the proteins. In support of this Some experimental data argue against an intrinsic specialization of cyclins and support a scenario in which idea, we found that substitution of the C-terminal part of Cln2p for that of Cln1p in the Cln2p N -Cln1p C chithe apparent functional specificity of the cyclin-CDK complexes reflects simply differences in the timing of mera causes the loss of the Cln2p-specific functionality, thirds of Cln2p, however, are not sufficient to confer more specialized than previously suspected.
